Device Trial Radar · NCT05113979
Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery
Last checked: Nov 20, 2026Latest source record: Apr 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Mar 9, 2020
Primary completion
Sep 9, 2022
Study completion Sep 9, 2022
Sponsor
- Lead sponsor
- OnPoint Vision IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 9, 2021
Design
- Study type
- Interventional
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To determine if the intraocular pseudophakic contact lens (IOPCL), referred to as the AccuraSee, corrects residual refractive errors after cataract surgery using a plus powered lens in subjects with ocular pathology previously implanted with a Bausch and Lomb LI61AO or LI61SE monofocal posterior chamber intraocular lens (PCIOL) and to confirm its positional stability and adherence relative to the PCIOL.
Conditions
- Refractive Errors
Interventions
AccuraSee IOPCL with +3.0D addDevice
The IOPCL (intraocular pseudophakic contact lens) consists of a 4.5mm diameter optic. All subjects will receive a +3.0 power regardless of diopter power based on IOL Master. This IOPCL will be coupled to a Bausch and Lomb Model LI61SE or LI61AO intraocular lens to correct residual refractive errors after cataract surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subjects With Stable Manifest Refraction Spherical Equivalent (MRSE)Time frame: Assessed all postoperative consecutive visit pairings beginning with 1 month visit (1 month to 4 months; 4 months to 1 year); reported for "Postoperative period between 1 month and 1 year"
- Subjects With Successful Delivery of AccuraSee IOPCLTime frame: 7-14 days visit
- Long Term Adherence and Positional Stability: Number of Participants With Greater or Less Than +/- 10 Microns Change in Gap Between the Pseudophakic Intraocular Lens and AccuraSee Intraocular Pseudophakic Contact LensTime frame: Assessed at 30-60 days visit and 120-180 days visit, 120-180 days visit reported
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chu Vision Institute
Bloomington, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.